Company

Telios Pharma, Inc.

Biotechnology Research 275 Shoreline Drive 38 employees

Employees: 38
Contacts: 4
Emails: 4
Phones: 2

Telios Pharma, Inc. Overview

Headquarters: 275 Shoreline Drive
Industry: Biotechnology Research
Employees: 38
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Inflammatory Diseases Allergy Oncology

About Telios Pharma, Inc.

Telios Pharma is a privately held clinical stage biopharmaceutical company with first-in-class topical and oral BTK inhibitor programs targeting mast cell-mediated inflammation and allergy. Launched in 2019 by proven industry veterans, we have brought together a team of scientists and clinicians with deep therapeutic expertise, and an experienced leadership team. We are passionate, collaborative and dedicated to our mission of improving the lives of patients with inflammatory diseases.

Telios Pharma, Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Telios Pharma, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Todd Covey	Cso at Kartos Therapeutics Cso	San Carlos, California, United States	Email Phone
Cecile Krejsa	Translational Pharmacology	Seattle, Washington, United States	Email Phone
Roger Ulrich		Greater Seattle Area, United States	Email
Susan (Wagener) Dyrseth, Ms		Rochester-austin, Minnesota Area, United States	Email